Cargando…
Expression analysis following argon treatment in an in vivo model of transient middle cerebral artery occlusion in rats
BACKGROUND: Argon treatment following experimental neurotrauma has been found neuroprotective in an array of in vivo and in vitro models. The inherent cellular and molecular mechanisms are still unknown. We seeked to shed light on these processes by examinig the cellular distribution and the express...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322493/ https://www.ncbi.nlm.nih.gov/pubmed/25671080 http://dx.doi.org/10.1186/2045-9912-4-11 |
_version_ | 1782356392355561472 |
---|---|
author | Fahlenkamp, Astrid V Coburn, Mark de Prada, Antonio Gereitzig, Nadine Beyer, Cordian Haase, Hajo Rossaint, Rolf Gempt, Jens Ryang, Yu-Mi |
author_facet | Fahlenkamp, Astrid V Coburn, Mark de Prada, Antonio Gereitzig, Nadine Beyer, Cordian Haase, Hajo Rossaint, Rolf Gempt, Jens Ryang, Yu-Mi |
author_sort | Fahlenkamp, Astrid V |
collection | PubMed |
description | BACKGROUND: Argon treatment following experimental neurotrauma has been found neuroprotective in an array of in vivo and in vitro models. The inherent cellular and molecular mechanisms are still unknown. We seeked to shed light on these processes by examinig the cellular distribution and the expression of inflammatory markers and growth factors in argon treated brain tissue. METHODS: Male adult Sprague-Dawley rats were randomly assigned to one of the study groups: sham surgery + placebo, sham surgery + argon, tMCAO + placebo, and tMCAO + argon. Animals underwent 2 h-transient middle cerebral artery occlusion (tMCAO) using the endoluminal thread model or sham surgery without tMCAO. After the first hour of tMCAO or sham surgery a 1 h inhalative argon (50% argon/50% O(2)) or placebo (50% N(2)/50% O(2)) treatment was performed. Brains were removed and evaluated after 24 h. RealTime-PCR was performed from biopsies of the penumbra and contralateral corresponding regions. Paraffin sections were immunostained with antibodies against GFAP, NeuN, and Iba1. Cell counts of astrocytes, neurons and microglia in different cortical regions were performed in a double-blinded manner. RESULTS: Fifteen animals per tMCAO group and twelve sham + placebo respectively eleven sham + argon animals completed the interventional procedure. We identified several genes (IL-1β, IL-6, iNOS, TGF-β, and NGF) whose transcription was elevated 24 h after the study intervention, and whose expression levels significantly differed between argon treatment and placebo following tMCAO. Except for the core region of ischemia, cell numbers were comparable between different treatment groups. CONCLUSION: In our study, we found an elevated expression of several inflammatory markers and growth factors following tMCAO + argon compared to tMCAO + placebo. Although conflicting the previously described neuroprotective effects of argon following experimental ischemia, these findings might still be associated with each other. Further studies will have to evaluate their relevance and potential relationship. |
format | Online Article Text |
id | pubmed-4322493 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-43224932015-02-11 Expression analysis following argon treatment in an in vivo model of transient middle cerebral artery occlusion in rats Fahlenkamp, Astrid V Coburn, Mark de Prada, Antonio Gereitzig, Nadine Beyer, Cordian Haase, Hajo Rossaint, Rolf Gempt, Jens Ryang, Yu-Mi Med Gas Res Research BACKGROUND: Argon treatment following experimental neurotrauma has been found neuroprotective in an array of in vivo and in vitro models. The inherent cellular and molecular mechanisms are still unknown. We seeked to shed light on these processes by examinig the cellular distribution and the expression of inflammatory markers and growth factors in argon treated brain tissue. METHODS: Male adult Sprague-Dawley rats were randomly assigned to one of the study groups: sham surgery + placebo, sham surgery + argon, tMCAO + placebo, and tMCAO + argon. Animals underwent 2 h-transient middle cerebral artery occlusion (tMCAO) using the endoluminal thread model or sham surgery without tMCAO. After the first hour of tMCAO or sham surgery a 1 h inhalative argon (50% argon/50% O(2)) or placebo (50% N(2)/50% O(2)) treatment was performed. Brains were removed and evaluated after 24 h. RealTime-PCR was performed from biopsies of the penumbra and contralateral corresponding regions. Paraffin sections were immunostained with antibodies against GFAP, NeuN, and Iba1. Cell counts of astrocytes, neurons and microglia in different cortical regions were performed in a double-blinded manner. RESULTS: Fifteen animals per tMCAO group and twelve sham + placebo respectively eleven sham + argon animals completed the interventional procedure. We identified several genes (IL-1β, IL-6, iNOS, TGF-β, and NGF) whose transcription was elevated 24 h after the study intervention, and whose expression levels significantly differed between argon treatment and placebo following tMCAO. Except for the core region of ischemia, cell numbers were comparable between different treatment groups. CONCLUSION: In our study, we found an elevated expression of several inflammatory markers and growth factors following tMCAO + argon compared to tMCAO + placebo. Although conflicting the previously described neuroprotective effects of argon following experimental ischemia, these findings might still be associated with each other. Further studies will have to evaluate their relevance and potential relationship. BioMed Central 2014-06-06 /pmc/articles/PMC4322493/ /pubmed/25671080 http://dx.doi.org/10.1186/2045-9912-4-11 Text en Copyright © 2014 Fahlenkamp et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Fahlenkamp, Astrid V Coburn, Mark de Prada, Antonio Gereitzig, Nadine Beyer, Cordian Haase, Hajo Rossaint, Rolf Gempt, Jens Ryang, Yu-Mi Expression analysis following argon treatment in an in vivo model of transient middle cerebral artery occlusion in rats |
title | Expression analysis following argon treatment in an in vivo model of transient middle cerebral artery occlusion in rats |
title_full | Expression analysis following argon treatment in an in vivo model of transient middle cerebral artery occlusion in rats |
title_fullStr | Expression analysis following argon treatment in an in vivo model of transient middle cerebral artery occlusion in rats |
title_full_unstemmed | Expression analysis following argon treatment in an in vivo model of transient middle cerebral artery occlusion in rats |
title_short | Expression analysis following argon treatment in an in vivo model of transient middle cerebral artery occlusion in rats |
title_sort | expression analysis following argon treatment in an in vivo model of transient middle cerebral artery occlusion in rats |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322493/ https://www.ncbi.nlm.nih.gov/pubmed/25671080 http://dx.doi.org/10.1186/2045-9912-4-11 |
work_keys_str_mv | AT fahlenkampastridv expressionanalysisfollowingargontreatmentinaninvivomodeloftransientmiddlecerebralarteryocclusioninrats AT coburnmark expressionanalysisfollowingargontreatmentinaninvivomodeloftransientmiddlecerebralarteryocclusioninrats AT depradaantonio expressionanalysisfollowingargontreatmentinaninvivomodeloftransientmiddlecerebralarteryocclusioninrats AT gereitzignadine expressionanalysisfollowingargontreatmentinaninvivomodeloftransientmiddlecerebralarteryocclusioninrats AT beyercordian expressionanalysisfollowingargontreatmentinaninvivomodeloftransientmiddlecerebralarteryocclusioninrats AT haasehajo expressionanalysisfollowingargontreatmentinaninvivomodeloftransientmiddlecerebralarteryocclusioninrats AT rossaintrolf expressionanalysisfollowingargontreatmentinaninvivomodeloftransientmiddlecerebralarteryocclusioninrats AT gemptjens expressionanalysisfollowingargontreatmentinaninvivomodeloftransientmiddlecerebralarteryocclusioninrats AT ryangyumi expressionanalysisfollowingargontreatmentinaninvivomodeloftransientmiddlecerebralarteryocclusioninrats |